SE427030B - Forfarande for framstellning av bensofenonderivat med antikonvulsiv verkan - Google Patents
Forfarande for framstellning av bensofenonderivat med antikonvulsiv verkanInfo
- Publication number
- SE427030B SE427030B SE7508829A SE7508829A SE427030B SE 427030 B SE427030 B SE 427030B SE 7508829 A SE7508829 A SE 7508829A SE 7508829 A SE7508829 A SE 7508829A SE 427030 B SE427030 B SE 427030B
- Authority
- SE
- Sweden
- Prior art keywords
- anticonvulvic
- preparing
- procedure
- effect
- benzophenon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP49090566A JPS605599B2 (ja) | 1974-08-06 | 1974-08-06 | アミノベンゾフエノン誘導体の製造法 |
JP49090565A JPS604199B2 (ja) | 1974-08-06 | 1974-08-06 | アニリン系ジペプチド誘導体の製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7508829L SE7508829L (sv) | 1976-02-07 |
SE427030B true SE427030B (sv) | 1983-02-28 |
Family
ID=26432028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7508829A SE427030B (sv) | 1974-08-06 | 1975-08-05 | Forfarande for framstellning av bensofenonderivat med antikonvulsiv verkan |
Country Status (14)
Country | Link |
---|---|
US (1) | US4240957A (fr) |
AR (5) | AR213076A1 (fr) |
CA (1) | CA1181065A (fr) |
CH (4) | CH617668A5 (fr) |
DD (1) | DD119213A5 (fr) |
DE (1) | DE2535171C3 (fr) |
DK (1) | DK155088C (fr) |
ES (5) | ES440032A1 (fr) |
FR (1) | FR2281131A1 (fr) |
GB (1) | GB1511669A (fr) |
HU (1) | HU176016B (fr) |
MX (1) | MX3332E (fr) |
NL (1) | NL175789C (fr) |
SE (1) | SE427030B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA755197B (en) * | 1974-08-20 | 1976-07-28 | Hoffmann La Roche | Phenyl ketones |
EP1483241A4 (fr) * | 2002-03-08 | 2006-12-13 | Bristol Myers Squibb Co | Derives cycliques servant de modulateurs de l'activite du recepteur de la chimiokine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK132495C (da) * | 1967-07-03 | 1976-07-05 | Hoffmann La Roche | Analogifremgangsmade til fremstilling af benzophenoner |
GB1235381A (en) * | 1968-03-14 | 1971-06-16 | Leo Pharm Prod Ltd | New anilides and anilines |
US3745212A (en) * | 1970-11-19 | 1973-07-10 | Rohm & Haas | Method for evaluating pancreatic enzyme sufficiency and compounds useful therein |
US3893992A (en) * | 1970-11-19 | 1975-07-08 | Rohm & Haas | N-acylated peptides of amino aromatic sulfonic acids and their derivatives |
BE795418A (fr) * | 1972-05-24 | 1973-08-14 | Rohm & Haas | Procede d'acylation directe des acides aminobenzoiques |
JPS5133522B2 (fr) * | 1972-12-13 | 1976-09-20 |
-
1975
- 1975-07-31 CA CA000232782A patent/CA1181065A/fr not_active Expired
- 1975-08-04 NL NLAANVRAGE7509258,A patent/NL175789C/xx not_active IP Right Cessation
- 1975-08-05 SE SE7508829A patent/SE427030B/xx not_active IP Right Cessation
- 1975-08-05 HU HU75SI1485A patent/HU176016B/hu unknown
- 1975-08-05 AR AR259900A patent/AR213076A1/es active
- 1975-08-05 DK DK356475A patent/DK155088C/da active
- 1975-08-05 CH CH1020275A patent/CH617668A5/de unknown
- 1975-08-05 MX MX000859U patent/MX3332E/es unknown
- 1975-08-05 ES ES440032A patent/ES440032A1/es not_active Expired
- 1975-08-06 DD DD187724A patent/DD119213A5/xx unknown
- 1975-08-06 DE DE2535171A patent/DE2535171C3/de not_active Expired
- 1975-08-06 FR FR7524559A patent/FR2281131A1/fr active Granted
- 1975-08-06 GB GB32916/75A patent/GB1511669A/en not_active Expired
-
1977
- 1977-01-31 ES ES455504A patent/ES455504A1/es not_active Expired
- 1977-01-31 ES ES455506A patent/ES455506A1/es not_active Expired
- 1977-01-31 ES ES455505A patent/ES455505A1/es not_active Expired
- 1977-01-31 ES ES455507A patent/ES455507A1/es not_active Expired
- 1977-03-07 US US05/775,646 patent/US4240957A/en not_active Expired - Lifetime
- 1977-11-28 AR AR270154A patent/AR219307A1/es active
- 1977-11-28 AR AR270151A patent/AR213453A1/es active
- 1977-11-28 AR AR270153A patent/AR220325A1/es active
- 1977-11-28 AR AR270152A patent/AR215035A1/es active
-
1979
- 1979-05-17 CH CH461779A patent/CH627438A5/de unknown
- 1979-05-17 CH CH461879A patent/CH627439A5/de unknown
- 1979-09-12 CH CH827079A patent/CH627440A5/de unknown
Also Published As
Publication number | Publication date |
---|---|
DD119213A5 (fr) | 1976-04-12 |
DK356475A (da) | 1976-02-07 |
CH627440A5 (de) | 1982-01-15 |
CH627439A5 (de) | 1982-01-15 |
HU176016B (en) | 1980-11-28 |
US4240957A (en) | 1980-12-23 |
AR220325A1 (es) | 1980-10-31 |
ES455506A1 (es) | 1978-01-16 |
ES440032A1 (es) | 1977-06-01 |
DE2535171B2 (de) | 1979-05-23 |
DK155088C (da) | 1989-06-26 |
ES455504A1 (es) | 1978-01-16 |
MX3332E (es) | 1980-09-29 |
CH617668A5 (fr) | 1980-06-13 |
NL175789B (nl) | 1984-08-01 |
FR2281131A1 (fr) | 1976-03-05 |
FR2281131B1 (fr) | 1980-04-18 |
AR219307A1 (es) | 1980-08-15 |
DE2535171A1 (de) | 1976-02-19 |
DK155088B (da) | 1989-02-06 |
NL175789C (nl) | 1985-01-02 |
SE7508829L (sv) | 1976-02-07 |
AR213076A1 (es) | 1978-12-15 |
AR215035A1 (es) | 1979-08-31 |
ES455507A1 (es) | 1978-01-16 |
CA1181065A (fr) | 1985-01-15 |
NL7509258A (nl) | 1976-02-10 |
GB1511669A (en) | 1978-05-24 |
CH627438A5 (de) | 1982-01-15 |
ES455505A1 (es) | 1978-01-16 |
DE2535171C3 (de) | 1980-01-24 |
AU8373475A (en) | 1977-02-10 |
AR213453A1 (es) | 1979-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE428562C (sv) | Forfarande for framstellning av purinderivat | |
SE420921B (sv) | Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan | |
SE423633B (sv) | Forfarande for framstellning av 4-demetoxi-daunomycin | |
SE415761B (sv) | Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan | |
SE420727B (sv) | Analogiforfarande for framstellning av bispidin- och bispidonderivat | |
SE412066B (sv) | Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat | |
SE431211B (sv) | Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner | |
SE409452B (sv) | Forfarande for framstellning av stilbenderivat | |
SE421612B (sv) | Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin | |
SE7506237L (sv) | Forfarande for framstellning av dekahydroisokinolinderivat | |
SE422052B (sv) | Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat | |
SE418292B (sv) | Forfarande for framstellning av 5-aryl-2-furamidiner | |
SE423390B (sv) | Foerfarande foer framstaellning av eburnameninderivat | |
SE425739B (sv) | Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat | |
SE440907B (sv) | Forfarande for framstellning av imidazolderivat med farmaceutisk verkan | |
SE422202B (sv) | Forfarande for framstellning av amidoximderivat | |
SE414926B (sv) | Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler | |
SE7512292L (sv) | Forfarande for framstellning av naftalenforeningar med terapeutisk verkan | |
SE415658B (sv) | Analogiforfarande for framstellning av linnolinderivat | |
SE7513739L (sv) | Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat | |
SE404364B (sv) | Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat | |
SE425784B (sv) | Analogiforfarande for framstellning av eburnameninderivat | |
SE388854B (sv) | Forfarande for framstellning av fenylpyridylaminderivat | |
SE7506196L (sv) | Forfarande for framstellning av amidin-hydrazon-derivat | |
SE427030B (sv) | Forfarande for framstellning av bensofenonderivat med antikonvulsiv verkan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7508829-4 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7508829-4 Format of ref document f/p: F |